|
IMMUNOSUPPRESSIVE AGENTS
Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006. In the meantime, thank you for your patience.
|
|
|
| Adalimumab | | For treatment of rheumatoid arthritis |
| Alefacept | | For treatment of moderate to severe chronic plaque psoriasis |
| Anakinra | | For treatment of adult rheumatoid arthritis |
| Antithymocyte globulin | | For prevention of renal transplant rejection |
| Basiliximab | | For prophylactic treatment of kidney transplant rejection |
| Daclizumab | | For prevention of renal transplant rejection |
| Efalizumab | | For treatment of psoriasis |
| Etanercept | | For treatment of severe adult and juvenille rheumatoid arthritis |
| Infliximab | | For treatment of Crohn's disease, psoriasis, rheumatoid arthitis and ankylosing spondylitis |
| Leflunomide | | For the treatment of active rheumatoid arthritis (RA) |
| Methotrexate | | For the treatment of gestational choriocarcinoma, chorioadenoma destruens and hydatidiform mole; Severe psoriasis; Severe, active, classical or definite rheumatoid arthritis; |
| Muromonab | | For treatment of organ transplant recipients, prevention of organ rejection |
| Sirolimus | | For the treatmnet of post operative pain |
| Tacrolimus | | Tacrolimus is indicated for the prophylaxis of organ rejection in patients |
|
|
|
